Investtech's Model Portfolios fell in the third quarter with, on average, 5.7 percentage points in relation to the reference index.
Market | Excess ret. Q1* | Excess ret. Q2* | Excess ret. Q3* | Excess ret. Q4* | Excess ret. 2007 |
Stockholm | -6.3% | +11.0% | -5.0% | -0.4% | |
Helsinki | -1.0% | +7.5% | -7.9% | -1.5% | |
Amsterdam | +0.7% | +12.5% | -2.6% | +10.6% | |
Copenhagen | -1.1% | +3.6% | -6.3% | -3.8% | |
Oslo | +1.5% | +6.9% | -6.0% | +2.4% | |
London | +2.6% | 0.0% | -7.2% | -4.7% | |
Frankfurt/CDAX | +3.6% | -17.3% | -3.8% | -17.5% | |
Nasdaq | +7.9% | -5.8% | -6.4% | -4.3% | |
Average | +1.0% | +2.3% | -5.7% | -2.4% |
For the duration of this period, emphasis has been placed on the shares in the portfolio reflecting the market’s composition, and the risks for the portfolio being of the same degree as those for the market. We believe the poor result for the last quarter is first and foremost due to statistical coincidences. It can also be due to the market, on the whole, being negative (moving sideways) during the period, since buy signals (which are often the reason for stocks being chosen for the portfolio) in such situations seldom give results.
The strategy use previously is still considered to be good.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.